Paul B. Fitzgerald, MD, PhD

  • 6Articles
  • 48.6KReads
  • 2010–2023Active
  • 27Collaborators
  • 295Citations

About

Paul B. Fitzgerald, MD, PhD, is affiliated with the Australian National University School of Medicine and Psychology in Canberra, Australia. Since 2010, Fitzgerald has published extensively on neurostimulation treatments such as repetitive transcranial magnetic stimulation and electroconvulsive therapy for conditions including treatment-resistant depression, bipolar disorder, obsessive-compulsive disorder, and suicidal ideation. His work also addresses clinical challenges related to clozapine use, including myocarditis and rechallenge protocols. Frequent collaborators include Daniel M. Blumberger, Zafiris J. Daskalakis, Andrew J. Taylor, Benoit H. Mulsant, and Cory R. Weissman.

Publications

JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al
JCP
Original Research

Continuation MST for Treatment-Resistant Depression

October 19, 2021

Magnetic seizure therapy (MST) has shown promise as an alternative to electroconvulsive therapy for acute treatment-resistant depression (TRD). This study examines the efficacy of MST as a continuation treatment...
, , , et al
JCP
Original Research

Does rTMS Decrease Suicidal Ideation?

April 17, 2018

Read a study on the effects of rTMS on suicidal ideation in patients with treatment-resistant major depression (TRD).
, , , et al
JCP
Review Article

Electroconvulsive Therapy for OCD

July 22, 2015

Read a full review on whether electroconvulsive therapy (ECT) is an effective treatment for OCD in patients.
, , , et al
JCP
Letter to the Editor

Observations From 8 Cases of Clozapine Rechallenge After Development of Myocarditis

February 15, 2012

, , , et al
JCP
Original Research

Diagnostic Characteristics of Clozapine-Induced Myocarditis Identified by an Analysis of 38 Cases and 47 Controls

March 9, 2010

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe